ISM5939

· InSilico Medicine Hong Kong Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISM5939, covering 2025-12-10 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1]